Nortech Systems earnings release, August 12, 2026

Nortech Systems Inc (NSYS) · Form 8-K, Item 2.02 · Filed · SEC filing

Nortech Systems Reports Second Quarter Results

MINNEAPOLIS – August 12, 2026 – Nortech

Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace

& defense markets, reported financial results for the second quarter ended June 30, 2026.

2026 Q2 Highlights:

Management Commentary

“Nortech delivered a solid second quarter, with year-over-year revenue growth, improved gross margins, and continued positive operating income reflecting the benefits of our restructuring actions and disciplined execution,” said President & CEO, Jay D. Miller.

“We are encouraged by the continued strength of our bookings and our backlog, which we view as an important leading indicator of future business prospects, including opportunities in attractive markets such as Aerospace and Defense as well as Medical.

We are also seeing continued customer interest in nearshoring and regional manufacturing strategies, where our North American footprint, combined with our China operations, positions Nortech well to support customers’ evolving supply chain needs. As we move through the second half of 2026, we remain focused on converting strong customer engagement into sustainable growth and long-term value.”

Summary Financial Information

The following table provides summary financial information comparing the second quarter 2026 (“Q2 2026”) financial results to the same quarter in 2025 (“Q2 2025”) as well as the six-month period ended June 30, 2026 (“YTD 2026”) with the same period in 2025 (“YTD 2025”).

Conference Call

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Wednesday, August 12, to discuss the Company’s 2026 second quarter results.

The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer and

Senior Vice President of Finance. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 979013. Participants may also access the call via webcast at: https://www.webcaster5.com/Webcast/Page/2814/54239.

###

About Nortech Systems

Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components.

Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock

Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Financial statements

Income Statement (in thousands)

Q2 2026Q2 2025% ChangeYTD 2026YTD 2025% Change
Net sales33,54030,6759.3%63,85657,57010.9%
Gross profit5,7034,83717.9%10,4057,91531.5%
Operating expenses5,0804,09524.1%9,7358,78610.8%
Net income (loss)3163131.0%282-1,003-128.1%
EBITDA9381,073-12.6%1,288-193-767.4%
Adjusted EBITDA9381,073-12.6%1,288731664.0%

Income Statement

THREE MONTHS ENDED — (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

THREE MONTHS ENDED – JUNE 30, – 2026THREE MONTHS ENDED – JUNE 30, – 2025SIX MONTHS ENDED – JUNE 30, – 2026SIX MONTHS ENDED – JUNE 30, – 2025
Net sales33,54030,67563,85657,570
Cost of goods sold27,83725,83853,45149,655
Gross profit5,7034,83710,4057,915
Operating expenses:Selling1,4841,2042,8152,388
Operating expenses:General and administrative3,2502,5896,2645,504
Operating expenses:Research and development346302656628
Operating expenses:Restructuring charges266
Operating expenses:Total operating expenses5,0804,0959,7358,786
Operating expenses:Income (loss) from operations623742670-871
Other expense:Interest expense, net-197-257-453-471
Other expense:Income (loss) before income taxes426485217-1,342
Other expense:Income tax expense (benefit)110172-65-339
Other expense:Net income (loss)316313282-1,003
Net income (loss) per common share:Basic (in dollars per share)0.110.120.1-0.36
Net income (loss) per common share:Weighted average number of common shares outstanding - basic (in shares)2,805,1832,773,5982,795,6592,767,263
Net income (loss) per common share:Diluted (in dollars per share)0.110.120.09-0.36
Net income (loss) per common share:Weighted average number of common shares outstanding - diluted (in shares)2,999,0022,954,7653,007,4392,767,263
Other comprehensive income (loss)Foreign currency translation2112490130
Other comprehensive income (loss)Comprehensive income (loss), net of tax337437372-873

Income Statement (in millions)

Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2023Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2023Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2023Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2024Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2024Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2024Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2024Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2025Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2025Last Twelve Months (“LTM”) Ended in Quarter(1) – Q3 2025Last Twelve Months (“LTM”) Ended in Quarter(1) – Q4 2025Last Twelve Months (“LTM”) Ended in Quarter(1) – Q1 2026Last Twelve Months (“LTM”) Ended in Quarter(1) – Q2 2026
Net Sales140.8138.9139.3138.7137.5135.6128.1120.8117.6116.7118.4121.8124.7
Gross Profit $ - Adjusted22.421.423.123.122.220.716.714.414.615.81819.620.5
Gross Margin % - Adjusted15.915.416.616.616.115.313.111.912.413.515.216.116.4
EBITDA - Adjusted6.8688.17.35.92.1-0.5-0.40.72.53.93.7

Balance Sheet

JUNE 30, 2026 — (IN THOUSANDS, EXCEPT SHARE DATA)

JUNE 30, 2026DECEMBER 31, 2025
Current assets:Cash1,3801,655
Current assets:Restricted cash294
Current assets:Accounts receivable, less allowance for credit losses of $154 and $161, respectively19,85016,998
Current assets:Inventories, net24,51220,695
Current assets:Contract assets16,97915,184
Current assets:Prepaid assets and other assets1,2791,618
Current assets:Total current assets64,29456,150
Current assets:Property and equipment, net4,9775,203
Current assets:Operating lease assets, net6,4207,016
Current assets:Deferred tax assets3,9633,394
Current assets:Other intangible assets, net147156
Current assets:Deferred line of credit issuance costs, net244
Current assets:Total assets80,04571,919
Current liabilities:Lines of credit7,8687,000
Current liabilities:Current portion of term loan, net of debt issuance costs432
Current liabilities:Accounts payable14,94912,809
Current liabilities:Accrued payroll and commissions2,8081,822
Current liabilities:Customer deposits6,8485,386
Current liabilities:Current portion of operating leases1,2461,332
Current liabilities:Current portion of finance lease obligations243274
Current liabilities:Other accrued liabilities1,6441,221
Current liabilities:Total current liabilities36,03829,844
Long-term liabilities:Term loan, net of debt issuance costs1,636
Long-term liabilities:Long-term operating lease obligations5,9296,476
Long-term liabilities:Long-term finance lease obligations534626
Long-term liabilities:Other long-term liabilities434426
Long-term liabilities:Total long-term liabilities8,5337,528
Long-term liabilities:Total liabilities44,57137,372
Shareholders’ equity:Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding250250
Shareholders’ equity:Common stock - $0.01 par value; 9,000,000 shares authorized; 2,853,766 and 2,786,134 shares issued and outstanding, respectively2928
Shareholders’ equity:Additional paid-in capital18,40917,855
Shareholders’ equity:Accumulated other comprehensive loss-619-709
Shareholders’ equity:Retained earnings17,40517,123

Cash Flow

SIX MONTHS ENDED JUNE 30, — (IN THOUSANDS) (in thousands)

SIX MONTHS ENDED JUNE 30, – 2026SIX MONTHS ENDED JUNE 30, – 2025
CASH FLOWS FROM OPERATING ACTIVITIESNet income (loss)282-1,003
Adjustments to reconcile net income (loss) to net cash used in operating activities:Depreciation and amortization618678
Adjustments to reconcile net income (loss) to net cash used in operating activities:Compensation on stock-based awards320235
Adjustments to reconcile net income (loss) to net cash used in operating activities:Change in allowance for credit losses-710
Adjustments to reconcile net income (loss) to net cash used in operating activities:Change in inventory reserves-311351
Adjustments to reconcile net income (loss) to net cash used in operating activities:Deferred taxes-569-700
Changes in current operating items:Accounts receivable-2,705-2,842
Changes in current operating items:Inventories-3,5302,714
Changes in current operating items:Contract assets-1,795-1,192
Changes in current operating items:Prepaid expenses and other assets338-1,647
Changes in current operating items:Accounts payable2,077295
Changes in current operating items:Accrued payroll and commissions978-94
Changes in current operating items:Customer deposits1,46336
Changes in current operating items:Other accrued liabilities392386
Changes in current operating items:Net cash used in operating activities-2,449-2,773
CASH FLOWS FROM INVESTING ACTIVITIESProceeds from sale of property and equipment9
CASH FLOWS FROM INVESTING ACTIVITIESPurchases of property and equipment-323-367
CASH FLOWS FROM INVESTING ACTIVITIESNet cash used in investing activities-323-358
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from lines of credit35,06151,405
CASH FLOWS FROM FINANCING ACTIVITIESPayments to line of credit-34,198-48,485
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from term loan2,200
CASH FLOWS FROM FINANCING ACTIVITIESPayments of debt issuance costs-290
CASH FLOWS FROM FINANCING ACTIVITIESPrincipal payments on term loan-110
CASH FLOWS FROM FINANCING ACTIVITIESPrincipal payments on financing leases-124-85
CASH FLOWS FROM FINANCING ACTIVITIESStock award exercises23523
CASH FLOWS FROM FINANCING ACTIVITIESNet cash provided by financing activities2,7742,858
CASH FLOWS FROM FINANCING ACTIVITIESEffect of exchange rate changes on cash and restricted cash179
CASH FLOWS FROM FINANCING ACTIVITIESNet change in cash and restricted cash19-264
CASH FLOWS FROM FINANCING ACTIVITIESCash and restricted cash - beginning of period1,655916
CASH FLOWS FROM FINANCING ACTIVITIESCash and restricted cash - end of period1,674652
Full release

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform

Act of 1995 including without limitation statements regarding strength and growth of bookings and backlog, future business prospects, opportunities in aerospace and defense and medical markets, converting strong customer engagement into sustainable growth and long-term value, future financial results including increased gross margin, our ability to generate positive EBITDA, nearshoring as a strategic advantage, successful execution of our long-term strategy, our enhanced competitiveness in aerospace, defense, and other high-reliability markets, and effects of restructuring and consolidating manufacturing facilities. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties.

Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

(1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products;

(4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions including changing tariff environment; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; (11) challenges with customers with respect to moving production from one facility to another Company owned facility or (12) financing cost increases and continued availability. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial... (truncated)ng the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting

Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under

GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Nortech Systems earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.